Evolent Health, Inc. to Release Third Quarter 2017 Operating Results and Host Conference Call on Thursday, November 2, 2017
WASHINGTON, Oct. 19, 2017 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent") will release its third quarter 2017 operating results on Thursday, November 2, 2017 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.
Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 855.940.9467 or 412.317.6034 for international callers, and referencing the "Evolent Health call" 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of Evolent's website and an audio file of the call will also be archived for 90 days at ir.evolenthealth.com.
About Evolent Health Evolent Health partners with leading provider organizations to achieve superior clinical and financial results in value-based care. With a provider heritage and over 20 years of health plan administration experience, Evolent operates in more than 30 U.S. health care markets, actively managing care across Medicare, Medicaid, commercial and self-funded adult and pediatric populations. With the experience to drive change, Evolent confidently stands by a commitment to achieve results. For more information, visit evolenthealth.com.
Therapist Cara Behan LMFT, launches Yoga & Meditation Membership in effort to address growing mental health crisis and need for accessible care in communities across California. A Licensed Marriage and Family Therapist, certified yoga teacher, and...
A new study by surgeon-scientists at Hospital for Special Surgery (HSS) found that 25% of patients with hip impingement who underwent modern arthroscopy for their condition experienced a delay in the natural progression of osteoarthritis. The...
Starting next week, the Network of National Library of Medicine and Columbus Metropolitan Library in Columbus, OH will host the All of Us Journey. This traveling educational exhibit brings the National Institutes of Health's All of Us Research...
$56.5M Equity Financing Led by Questa Capital, Laerdal Million Lives Fund, and Catalyst Health Ventures, with New Participation from RC Capital and Eckuity CapitalAvive has rapidly built an expansive and diverse customer base, delivering its FDA...
Lynx Dx, a leader in innovative diagnostic solutions, hailed new peer-reviewed research published today in the Journal of the American Medical Association (JAMA) Oncology that validates the efficacy of MyProstateScore 2.0 (MPS2), the company's...
Data infrastructure and analytics company Kalderos, Inc., today announced that on Tuesday, April 16, it asked the Eighth Circuit for leave to file an amicus brief in support of Pharmaceutical Research and Manufacturers of America's (PhRMA's) petition...
